Aftercare

Reducing 30-Day Readmissions After Vascular Surgery: Discharge Documentation and Patient Monitoring Strategies

Vascular surgery patients carry a high burden of comorbid cardiovascular disease, diabetes, renal insufficiency, and smoking-related disease that elevates their risk for post-operative complications and 30-day readmission. Per ACS NSQIP registry analyses, 30-day readmission rates for major vascular procedures including open aortic repair and lower extremity bypass exceed 15 percent in many cohorts. Discharge documentation that addresses wound surveillance, graft or stent monitoring, medication adherence, and cardiovascular event recognition is the primary modifiable factor within a vascular surgery practice's control for reducing preventable readmission. This guide covers the discharge documentation strategies and patient monitoring criteria most associated with readmission reduction across the major vascular procedure categories.

Wound and Incision Surveillance After Vascular Procedures

Surgical site infection and wound complication are leading causes of 30-day readmission after vascular procedures involving groin incisions, including femoral cutdown for endovascular access, femoral-popliteal bypass, and aorto-femoral bypass. The groin is a high-risk wound location due to proximity to skin folds, the lymphatic disruption associated with groin dissection, and the high bacterial colonization in the inguinal region. Discharge instructions for procedures involving groin incisions must specify wound monitoring criteria that distinguish expected post-operative ecchymosis and swelling from early wound complication signs: increasing erythema extending beyond the immediate peri-incisional margin, induration, warmth, serous or purulent drainage, wound separation, or lymphorrhea. Patients with diabetes or obesity face elevated wound complication risk and may benefit from earlier scheduled wound checks.
Hematoma and pseudoaneurysm surveillance instructions are required for patients who underwent open arterial access or percutaneous femoral access with arterial closure device use. A palpable pulsatile mass at a femoral access site developing within days to weeks of the procedure is the clinical presentation of a femoral pseudoaneurysm and requires duplex ultrasound evaluation. Discharge instructions should specify that any new pulsatile bulge or rapidly enlarging non-pulsatile mass at a groin or extremity access site warrants prompt provider contact for imaging evaluation. Expanding hematomas may require operative drainage, and pseudoaneurysms may require ultrasound-guided thrombin injection or operative repair depending on size and clinical presentation.
Lymphocele and lymphorrhea instructions are relevant for patients who underwent procedures requiring groin lymphatic disruption, including femoral artery bypass and ilio-femoral venous procedures. Lymphorrhea, defined as persistent clear or straw-colored drainage from the wound, is a specific wound complication that differs from infection in its clinical presentation and management. Discharge instructions should distinguish lymphorrhea from early wound infection, specify the wound drainage characteristics that indicate lymphorrhea versus infection, and instruct the patient that persistent clear drainage beyond 5 to 7 days without wound closure warrants provider contact. Untreated lymphorrhea can progress to wound dehiscence and serve as a portal for secondary infection.
Incision monitoring after endovascular aortic repair (EVAR) via bilateral groin access requires attention to both access site wounds and to flank or abdominal discomfort that may indicate an expanding retroperitoneal hematoma or early endoleak-related aortic sac pressurization. Discharge instructions should specify that groin wound complications after EVAR are managed similarly to other groin access wounds, but that any new back pain, abdominal distension, or hemodynamic symptoms in the early post-operative period warrant emergency evaluation rather than outpatient scheduling.

Graft and Stent Surveillance and Limb Monitoring

Graft and stent surveillance instructions are a required component of discharge documentation for patients who underwent lower extremity bypass, endovascular peripheral arterial intervention, carotid artery stenting, or endovascular aortic repair. The Society for Vascular Surgery (SVS) guidelines recommend duplex ultrasound surveillance of infrainguinal bypass grafts at defined intervals after surgery, beginning at 1 month and continuing at 3 months, 6 months, and annually thereafter, with the specific protocol dependent on graft material, conduit type, and inflow and outflow characteristics. Discharge instructions must reference the specific surveillance protocol the patient should follow and must identify the imaging provider or facility where surveillance will be performed.
Acute limb ischemia recognition instructions must be included in discharge documentation for all patients who underwent lower extremity arterial revascularization, whether by open bypass or endovascular intervention. The six Ps of acute limb ischemia (pain, pallor, pulselessness, paresthesia, paralysis, and poikilothermia) represent a vascular surgical emergency requiring immediate evaluation. Discharge instructions must use plain language to describe these symptoms in terms the patient can recognize, emphasizing that new onset of coolness, color change to pale or mottled, loss of sensation, weakness, or pain in the revascularized extremity that differs from baseline requires immediate emergency room presentation rather than a scheduled call.
Access site and stent thrombosis monitoring applies to patients who underwent percutaneous arterial interventions with stent placement in peripheral arteries, renal arteries, mesenteric arteries, or the carotid. Antiplatelet therapy adherence is critical to maintaining stent patency, and discharge instructions must specify the prescribed antiplatelet regimen, the duration of dual antiplatelet therapy where applicable, and the importance of not discontinuing antiplatelet medications without consulting the vascular surgeon. Stent thrombosis can cause acute limb ischemia in peripheral stents, renovascular hypertension or renal failure in renal stents, or stroke in carotid stents, and instructions must specify the symptoms relevant to the specific stent location.
Post-carotid endarterectomy discharge instructions must address stroke and transient ischemic attack recognition, wound monitoring for the cervical incision, and cranial nerve monitoring. Stroke symptoms after carotid endarterectomy, including new unilateral weakness, speech difficulty, facial droop, or visual disturbance, require immediate emergency evaluation and should be listed in the discharge instructions with explicit instruction to call 911 and proceed to the nearest emergency department. Cranial nerve dysfunction, including marginal mandibular nerve injury causing facial asymmetry, hypoglossal nerve injury causing tongue deviation, or vagal nerve injury causing hoarseness, may be present after CEA and should be documented in the discharge note, with the patient advised of expected recovery timeframes or the need for specialist referral if deficits persist.

Cardiovascular Event Prevention and Medication Adherence

Cardiovascular medication adherence instructions are a required component of discharge documentation for vascular surgery patients, given the high prevalence of coronary artery disease, congestive heart failure, hypertension, and hyperlipidemia in the vascular surgery population. ACS NSQIP data consistently identify cardiac events, including myocardial infarction and new congestive heart failure exacerbation, as leading causes of readmission and death in the 30 days following major vascular procedures. Discharge instructions must specify each cardiovascular medication, the dose, the frequency, and the indication, with particular emphasis on medications that should not be discontinued without physician guidance: statins, aspirin, P2Y12 inhibitors, beta-blockers, and ACE inhibitors or ARBs.
Blood pressure monitoring instructions after carotid endarterectomy and renal artery revascularization support early detection of hemodynamic instability. Hypertension and hypotension are both expected in the early post-operative period after CEA due to altered carotid baroreceptor function, and patients or their caregivers should receive guidance on home blood pressure monitoring and the blood pressure thresholds that require provider notification. After renal artery revascularization, improvement in blood pressure control or, paradoxically, new hypotension from over-correction of renovascular hypertension can occur, and discharge instructions should specify the expected blood pressure trajectory and the values requiring provider contact.
Anticoagulation monitoring instructions apply to patients discharged on warfarin or direct oral anticoagulants (DOACs) after vascular procedures. Patients discharged on warfarin require specific instructions on INR monitoring frequency and target range, dietary consistency recommendations affecting warfarin response, and the symptoms of over-anticoagulation (unusual bruising, blood in urine or stool, prolonged bleeding from minor cuts) requiring provider contact. Patients discharged on DOACs require instructions on dosing schedule adherence, the importance of not missing doses to maintain anticoagulant effect, and the need to notify all treating providers and pharmacies of the anticoagulant to prevent harmful drug interactions.
Fluid status and renal function monitoring instructions are relevant for patients with chronic kidney disease, congestive heart failure, or contrast exposure during endovascular procedures. Patients who received intravascular iodinated contrast during endovascular procedures and who have pre-existing renal insufficiency should receive discharge instructions addressing hydration guidance, the timeframe for peak contrast-induced nephropathy risk (24 to 72 hours post-procedure), and symptoms of significant renal function decline requiring outpatient laboratory evaluation or emergency care. Patients with congestive heart failure who underwent aortic or infrainguinal procedures may require specific fluid restriction instructions and daily weight monitoring with defined weight gain thresholds triggering provider contact.

Vascular Surgery Discharge Planning: Documentation Requirements and Post-Operative Care Instructions Readmission Reduction After Cardiac Surgery: Discharge Planning and Aftercare Documentation Requirements Readmission Reduction Strategies for General Surgery Practices Post-Operative Wound Care Documentation: Compliance Requirements and Aftercare Standards

Frequently asked

Questions patients ask.

What are the most common causes of 30-day readmission after lower extremity bypass?

Per ACS NSQIP and Society for Vascular Surgery (SVS) registry analyses, the most common causes of 30-day readmission after lower extremity bypass include wound complication at the groin incision (wound infection, lymphorrhea, and wound dehiscence), graft thrombosis or acute limb ischemia, cardiovascular events including myocardial infarction and congestive heart failure exacerbation, and uncontrolled pain. Discharge documentation addressing each of these risk categories with specific patient-facing monitoring criteria and escalation instructions is the primary practice-based strategy for reducing preventable readmission.

What graft surveillance instructions should be included in lower extremity bypass discharge documentation?

Lower extremity bypass discharge instructions should specify the graft surveillance protocol recommended by the Society for Vascular Surgery (SVS), which typically includes duplex ultrasound at 1 month, 3 months, 6 months, and annually thereafter. Instructions must identify the imaging provider or facility, confirm the first surveillance appointment before discharge, and include acute graft thrombosis symptoms requiring emergency evaluation: new or worsening pain, coolness, pallor, mottling, loss of sensation or motor function, or loss of a previously palpable pulse in the revascularized extremity.

What stroke symptoms should carotid endarterectomy discharge instructions include?

Carotid endarterectomy discharge instructions must specify stroke and TIA symptoms requiring immediate emergency evaluation: new unilateral arm or leg weakness, facial droop, speech difficulty, confusion, sudden severe headache, or visual disturbance. Instructions should direct patients to call 911 and go to the nearest emergency department, not to contact the surgical office first, in the event of these symptoms. Instructions should also address cranial nerve complications (hoarseness, tongue deviation, facial asymmetry) as distinct from stroke, with guidance on expected recovery timeframes.

What medication adherence content is most important in vascular surgery discharge instructions?

Vascular surgery discharge instructions should specifically address antiplatelet therapy adherence for patients with peripheral arterial stents or carotid stents, including the prescribed antiplatelet regimen, the duration of dual antiplatelet therapy, and the instruction not to discontinue antiplatelet medications without physician consultation. Statin and antihypertensive continuity should also be addressed. For patients on anticoagulation, instructions must specify the monitoring schedule, INR target range for warfarin patients, and symptoms of over-anticoagulation requiring provider contact.

For practices

Bring this to your own practice.

QR Rx turns every procedure into a branded recovery plan that keeps patients engaged and brings them back. Start free in minutes, or see it live in a 20-minute demo.

Start free trial

This blog provides general information about healthcare compliance and aftercare best practices. It does not constitute legal, medical, or regulatory advice. Consult qualified professionals for guidance specific to your practice.